Sort by

Send to

Choose Destination

Search results

Items: 5


Implementing an Integrated Pharmaceutical Management Information System for Antiretrovirals and Other Medicines: Lessons From Namibia.

Mabirizi D, Phulu B, Churfo W, Mwinga S, Mazibuko G, Sagwa E, Indongo L, Hafner T.

Glob Health Sci Pract. 2018 Dec 27;6(4):723-735. doi: 10.9745/GHSP-D-18-00157. Print 2018 Dec 27.


Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals.

Konduri N, Aboagye-Nyame F, Mabirizi D, Hoppenworth K, Kibria MG, Doumbia S, Williams L, Mazibuko G.

Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407. eCollection 2018 Jan-Dec.


Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.

Mutenda N, Bukowski A, Nitschke AM, Nakanyala T, Hamunime N, Mekonen T, Tjituka F, Mazibuko G, Mwinga S, Mabirizi D, Sagwa E, Indongo R, Dean N, Jordan MR, Hong SY.

PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.


Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison LP Jr, Stergachis A.

Drug Saf. 2016 Sep;39(9):859-72. doi: 10.1007/s40264-016-0432-y.


Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia.

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Baeten JM, Babigumira JB, Garrison LP, Stergachis A.

Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1052-60. doi: 10.1002/pds.4022. Epub 2016 May 2.


Supplemental Content

Loading ...
Support Center